Precision Health AI, a healthcare technology company focused on the application of artificial intelligence to cancer care, today announced the launch of the Eureka Health Oncology AI Platform. The 60+ set of pre-trained AI solution modules will utilize Precision Health AI’s proprietary data to predict a patient’s cancer stage, treatment journey, flow through the healthcare system and survival rate.
Driving the new Eureka Health Oncology AI platform is Precision Health AI’s deep, longitudinal dataset. Data acquired from a recent agreement with ASCO and CancerLinQ, combined with other data partners in EMR and genomics, provides Precision Health AI access to the largest oncology dataset available in the industry. Eureka HealthTM Oncology AI platform will augment the work of researchers, oncologists and insurers to reduce time spent on laborious, manual tasks and maximize workflow efficiencies throughout the oncology care ecosystem.
“Our team of healthcare professionals is using the deep clinical oncology dataset at our disposal to train innovative AI solutions for the management, delivery and use of clinical data that integrates seamlessly into existing workflows,” said Brigham Hyde, PhD, Chief Executive Officer of Precision Health AI in a statement. “The Eureka HealthTM Oncology AI platform will transform the clinical and drug development processes to include real-world data and speed of delivery to provide the right therapy to the right patient at the right time.”
